ETHYPHARM TO DEVELOP A FLASH VERSION OF AVENTIS' ALLEGRA.Ethypharm, one of the world's leading drug delivery system companies, Saint-Cloud, France, has entered into a co-development and licensing agreement to develop a Flash version of Aventis' drug Allegra Al·leg·ra A trademark for the drug fexofenadine hydrochloride. fexofenadine hydrochloride Allegra, Telfast (UK) Pharmacologic class: Peripherally selective piperidine, selective histamine (fexofenadine HCl). The Allegra Flash formulation will be the equivalent of a marketed version of Allegra, with the added advantages of Ethypharm's oral "pleasant tasting" and "melt in your mouth" Flashtab delivery technology. Under the terms of the agreement, Ethypharm will develop a novel version of Aventis' highly successful pharmaceutical Allegra based on its unique Flashtab technology. In turn, Aventis will be responsible for manufacturing, marketing and distribution of the new Flash version of Allegra worldwide including the US, Europe, Japan and Latin America Latin America, the Spanish-speaking, Portuguese-speaking, and French-speaking countries (except Canada) of North America, South America, Central America, and the West Indies. . The Flash version of Allegra would represent a new and convenient method of administration to patients. Ethypharm's proprietary Flashtab technology, which improves the palatability palatability (pal´  t of bad-tasting and difficult-to-swallow drugs, is a novel solution to the increasing demand from both doctors and consumers for the more convenient use of medicines; Flashtab is well adapted for people who have difficulties in swallowing, such as children or the elderly and is also perfectly suitable for active people who wish to take their medication without water. "This collaboration with Aventis highlights the real competitive advantages of our novel Flashtab technology," commented Patrice Debregeas, Ethypharm's chairman and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. . "The convenient delivery of medicines is becoming increasingly important to both the medical profession and consumers, and we are extremely gratified grat·i·fy tr.v. grat·i·fied, grat·i·fy·ing, grat·i·fies 1. To please or satisfy: His achievement gratified his father. See Synonyms at please. 2. that Aventis has approached us to address this market requirement with one of its most important products. This deal is one of a number of significant deals that we have signed for our Flashtab technology, which we fully expect to become one of the key technologies in the rapidly growing market for 'easy to use' medicines over the next decade," he added. About Flashtab Ethypharm 's proprietary technology Flashtab is used to improve the ease of administration and palatability of difficult-to-swallow and bad-tasting medicines. The technology combines two key proprietary technologies: fast melting and taste-masking. Flashtab tablets consist of microparticules that disperse disperse /dis·perse/ (dis-pers´) to scatter the component parts, as of a tumor or the fine particles in a colloid system; also, the particles so dispersed. dis·perse v. 1. quickly in the mouth thereby allowing the rapid and safe release of the active ingredients An active ingredient, also active pharmaceutical ingredient (or API), is the substance in a drug that is pharmaceutically active. Some medications may contain more than one active ingredient. into the organism. They can be administered anywhere, without the need for water or chewing chewing or mastication Up-and-down and side-to-side movements of the lower jaw, using the teeth to grind food for easier swallowing. During chewing, the tongue shapes food into a lump and saliva lubricates it for swallowing. . About Ethypharm Ethypharm is one of the world's leading drug delivery systems (DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S ) companies that provides effective solutions to optimize the delivery of active molecules into the body. The company's DDS technologies can improve drug efficacy, increase patient compliance and comfort, extend the life cycles of existing pharmaceutical products and reduce the total cost of treatment. The company has developed a broad range of technology platforms for both oral and injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. delivery, and now has 50 products sold in more than 70 countries. Founded in 1977 by Patrice Debregeas and Gerard Leduc, the company has more than 900 employees. Ethypharm's headquarters are located in Saint-Cloud, Paris and the company has operations in all of the world's key healthcare markets. Ethypharm has more than 100 clients worldwide including most of the world's major pharmaceutical companies. For more information, visit http://www.ethypharm.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion